Table 3.
Hyperprogressive disease.
Mechanism | Cause | Consequences | Citation |
---|---|---|---|
Genetic alteration | EGFR alteration and MDM2 amplification DNMT3a alteration |
Inhibition of p53 | (90, 91) |
Alteration in oncogenic pathways | Alteration of FGF2/β-catenin oncogene pathway | Escape through a T cell dependant mechanism | (92) |
Modification of the immune infiltration | Imbalance between Teff and regulatory T cells (Treg) Increased infiltration of Type 2 macrophages |
Escape through a T cell dependant mechanism Activated through the Fc portion of the ICIs |
(93) (91, 92, 94) |